Sun Pharma Advanced Research Company Limited (NSE: SPARC)
India
· Delayed Price · Currency is INR 201.48
+1.70 (0.85%)
Dec 27, 2024, 3:50 PM IST
NSE: SPARC Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -4,081 | -3,872 | -2,226 | -2,034 | -1,511 | -3,124 | Upgrade
|
| Depreciation & Amortization | 123.46 | 123.26 | 115.57 | 99.47 | 107.11 | 93.68 | Upgrade
|
| Other Amortization | 1.85 | 1.85 | 2.14 | 2.15 | 287.05 | 1.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.6 | -0.6 | 1.13 | -48.93 | -2.64 | -1.29 | Upgrade
|
| Loss (Gain) From Sale of Investments | -22.71 | -31.81 | -32.65 | -4.64 | -5.67 | -66.71 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.01 | 20.5 | - | - | - | - | Upgrade
|
| Other Operating Activities | -18.8 | -259.6 | 37.39 | 164.11 | 85.34 | -30.99 | Upgrade
|
| Change in Accounts Receivable | 183.24 | 152.14 | -50.06 | -101.46 | -15.44 | -58.31 | Upgrade
|
| Change in Accounts Payable | -271.6 | -58.9 | 766.68 | -193.58 | -599.16 | 717.75 | Upgrade
|
| Change in Other Net Operating Assets | -298.08 | -366.58 | 694.47 | 34.51 | 135.84 | 360.73 | Upgrade
|
| Operating Cash Flow | -4,384 | -4,292 | -691.18 | -2,082 | -1,519 | -2,108 | Upgrade
|
| Capital Expenditures | -250.38 | -265.08 | -153.87 | -326.78 | -59.95 | -540.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.75 | 4.85 | 4.65 | 81.02 | 48.18 | 3.91 | Upgrade
|
| Investment in Securities | 3,586 | 3,952 | -5,352 | -47.71 | 26.33 | 2,088 | Upgrade
|
| Other Investing Activities | 257.22 | 223.72 | 18.69 | 1.8 | 1.07 | 2.42 | Upgrade
|
| Investing Cash Flow | 3,599 | 3,915 | -5,483 | -291.67 | 15.62 | 1,553 | Upgrade
|
| Long-Term Debt Issued | - | 644.12 | 2,245 | 1,070 | 4,050 | 600 | Upgrade
|
| Total Debt Issued | 1,624 | 644.12 | 2,245 | 1,070 | 4,050 | 600 | Upgrade
|
| Long-Term Debt Repaid | - | -204.04 | -3,024 | -2,646 | -2,376 | -25.75 | Upgrade
|
| Total Debt Repaid | -771.64 | -204.04 | -3,024 | -2,646 | -2,376 | -25.75 | Upgrade
|
| Net Debt Issued (Repaid) | 852.19 | 440.09 | -778.17 | -1,576 | 1,674 | 574.25 | Upgrade
|
| Issuance of Common Stock | - | - | 7,028 | 4,093 | - | - | Upgrade
|
| Other Financing Activities | -23.64 | -16.04 | -82.07 | -223.01 | -81.29 | -19.64 | Upgrade
|
| Financing Cash Flow | 828.55 | 424.05 | 6,168 | 2,293 | 1,593 | 554.62 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.12 | 0.02 | - | -0.02 | 0.02 | - | Upgrade
|
| Net Cash Flow | 43.56 | 47.46 | -6.41 | -80.8 | 89.52 | 0.03 | Upgrade
|
| Free Cash Flow | -4,635 | -4,557 | -845.05 | -2,409 | -1,579 | -2,648 | Upgrade
|
| Free Cash Flow Margin | -771.36% | -603.21% | -35.39% | -175.53% | -62.42% | -344.79% | Upgrade
|
| Free Cash Flow Per Share | -14.28 | -14.04 | -2.97 | -9.16 | -6.03 | -10.11 | Upgrade
|
| Cash Interest Paid | 16.04 | 16.04 | 82.07 | 142.18 | 81.29 | 19.52 | Upgrade
|
| Cash Income Tax Paid | - | 41.11 | -53.65 | -45.44 | 16.31 | 98.59 | Upgrade
|
| Levered Free Cash Flow | -3,038 | -2,931 | -611.54 | -1,833 | -1,130 | -1,761 | Upgrade
|
| Unlevered Free Cash Flow | -3,023 | -2,924 | -563.82 | -1,750 | -1,064 | -1,744 | Upgrade
|
| Change in Net Working Capital | 308.4 | 210.88 | -870.12 | 299.15 | 487.41 | -670.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.